Загрузка...
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study
BACKGROUND: Tenofovir disoproxil fumarate (TDF) is key component of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) for HIV, but existing tools to monitor drug adherence are often inaccurate. Detection of tenofovir (TFV) in accessible biological samples, such as fingerprick blood, u...
Сохранить в:
| Опубликовано в: : | BMC Infect Dis |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5513124/ https://ncbi.nlm.nih.gov/pubmed/28705153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2593-4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|